chartexchange

NVSEF
NOVARTIS AG BASEL AKT
stockOTC

EODNov 17, 2026
159.45USD+0.115%(+0.18)355
Loading…
Loading…
349.17B
Healthcare
Drug Manufacturers-General
HQ
Basel, Basel Stadt, Switzerland
103,000
Previous Close
$159.26
Beta
0.60
52-Week High
$171.29 2026-02-26
52-Week Low
$123.69 2025-11-19
SMA 50
$148.84
SMA 200
$141.70
Avg. Vol 10D
81,832
Avg. Vol 30D
60,528
Avg. Vol 90D
40,117
Relative Vol
0.01
1.61B
NVSEF Profile

novartis provides healthcare solutions that improve and extend people's lives. we use science-based innovation to address some of society's most challenging healthcare issues. we discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. our company is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicines novartis is headquartered in basel, switzerland. novartis group companies employ approximately 120,000 associates and its products are available in more than 180 countries around the world. see our community guidelines: https://www.novartis.com/sites/www.novartis.com/files/linkedin-community-guidelines.pdf

NVSEF Performance
PeriodPriceDateChangeBeta
1W162.122026-11-11-1.65%2.092
1M146.462026-10-19+8.87%0.442
3M149.732026-08-18+6.49%0.775
6M149.062026-05-21+6.97%0.693
1Y127.132025-11-18+25.42%0.602
2Y105.002024-11-19+51.85%—
5Y80.972021-11-18+96.92%0.074
NVSEF Stock Summary

NOVARTIS AG BASEL AKT (OTC:NVSEF) stock price today is $159.45, and today's volume is 355. NVSEF is up 0.115% today. The 30 day average volume is 60,528. NVSEF market cap is $349.17B with 2.19B shares outstanding.